Once-daily INCRUSE is a prescription medicine used long term to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis, emphysema, or both, for better breathing and fewer flare-ups. INCRUSE is not used to relieve sudden breathing problems and won't replace a rescue inhaler.
ABOUT INCRUSE ELLIPTATalk to your doctor to see if INCRUSE is right for you.
INCRUSE ELLIPTA helps people with COPD breathe better for a full 24 hours. Your results may vary.
INCRUSE ELLIPTA is not for use to treat sudden symptoms of COPD. Always have a rescue inhaler (an inhaled, short-acting bronchodilator) with you to treat sudden symptoms. If you do not have a rescue inhaler, contact your healthcare provider to have one prescribed for you.
In a clinical study, patients took a disease-specific questionnaire, called the St. George’s Respiratory Questionnaire. They answered questions about their symptoms, activity, and impact of disease. More patients taking INCRUSE ELLIPTA had an improvement in total score on the questionnaire compared with patients taking an inactive treatment, called placebo; however, your results may vary.
INCRUSE is an anticholinergic medicine (also known as a LAMA).
Anticholinergic medicines help the muscles around the airways in your lungs stay relaxed to prevent COPD symptoms such as wheezing, cough, chest tightness, and shortness of breath. These symptoms can happen when the muscles around the airways tighten. This makes it hard to breathe.